Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$239K Buy
1,604
+167
+12% +$26K 0.04% 340
2021
Q2
$226K Buy
1,437
+833
+138% +$122K 0.04% 348
2021
Q1
$83K Sell
604
-512
-46% -$74.5K 0.02% 512
2020
Q4
$145K Buy
1,116
+90
+9% +$10K 0.03% 363
2020
Q3
$94K Buy
1,026
+190
+23% +$15.9K 0.02% 422
2020
Q2
$65K Sell
836
-1,070
-56% -$73.7K 0.02% 438
2020
Q1
$94K Buy
1,906
+695
+57% +$54.5K 0.04% 340
2019
Q4
$115K Buy
+1,211
New +$111K 0.05% 327

Other funds holding APTV

Eudaimonia Partners's APTV Position: Q3 2021 in Review

Eudaimonia Partners increased its Aptiv (APTV) stake by 12% in Q3 2021, buying an estimated $26K and bringing the position to 1,604 shares worth $239K. The position accounts for 0.04% of the portfolio, ranked #340.

Eudaimonia Partners first reported a position in APTV in Q4 2019 and has held it in 8 quarters since. 745 funds tracked by Wall St. Rank hold APTV as of Q3 2021.

  • Eudaimonia Partners held 1,604 shares of Aptiv worth $239K as of Q3 2021.
  • Eudaimonia Partners bought 167 Aptiv shares in Q3 2021, an estimated $26K.
  • Aptiv made up 0.04% of Eudaimonia Partners's portfolio in Q3 2021, its #340 holding.
  • Eudaimonia Partners first reported a position in Aptiv in Q4 2019 and has held it in 8 quarters since.
  • 745 funds tracked by Wall St. Rank held Aptiv as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.